Teva Pharmaceutical Industries (NYSE:TEVA) shares continued gains for seven straight sessions, as the stock closed 1% higher ...

NYSE:TEVA 1 Year Share Price vs Fair Value Explore Teva Pharmaceutical Industries's Fair Values from the Community ...

The Teva Flintwood men’s sandal is made for trailheads, riverbanks, and long summer days. Right now, Zappos has the Dark ...

One of the investment banks whose price target for Teva's stock is among the highest is Oppenheimer with a price target of ...

Teva's transformation boosts profit growth and specialty drugs, offering an undervalued opportunity. Click here to read my ...

Teva Pharmaceutical Industries reported a better than expected increase in second-quarter profit on Wednesday, helped by a 26 ...

Where do you fall in the Chaco Vs. Teva debate? We look at the merits of both footwear brands to help you choose the right sandals for your feet.

The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva Pharma , to help ...

Teva raised 2025 guidance for Austedo, Ajovy, and Uzedy after Q2 earnings beat estimates, despite missing revenue ...

Teva’s chief drug Austedo—approved in Huntington’s disease and tardive dyskinesia—grew sales 19% to $498 million for the ...

Teva has agreed to pay a whopping $1.2 billion to settle a US lawsuit claiming its subsidiary Cephalon paid to hold up generic competition to its narcolepsy therapy Provigil. In a statement, the ...

Teva Pharmaceutical Industries Ltd. TEVA 2.46% on Monday agreed to buy Allergan PLC’s generics unit for $40.5 billion in cash and stock, in a deal that will vault the Israeli company into the ...